Boon Hwa Andre Choo

Title: Boon Hwa Andre Choo: Innovator in Antibody Research

Introduction

Boon Hwa Andre Choo is a prominent inventor based in Singapore, known for his significant contributions to the field of antibody research. He holds a total of 10 patents, showcasing his innovative approach to developing therapeutic solutions.

Latest Patents

Among his latest patents, Choo has developed a cytotoxic antibody that binds to a glycosylated protein. This antibody targets specific glycan motifs, including Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1 and Fucα1-2Galβ1-3GlcNAc. Additionally, he has disclosed antibodies that exhibit cytotoxic effects against undifferentiated pluripotent cells. Another notable invention is the anti-AXL tyrosine kinase receptor antibodies, which are designed to bind to a glycan on the AXL receptor tyrosine kinase. These antigen-binding proteins can be conjugated to a radioisotope or cytotoxin, allowing for internalization into cells upon binding. His work also includes compositions that comprise a physiologically acceptable carrier and a therapeutically effective amount of the antigen-binding protein, along with methods for detecting cancer.

Career Highlights

Choo has worked with esteemed organizations such as the Agency for Science, Technology and Research and Immune System Therapeutics Ltd. His career reflects a commitment to advancing medical research and developing innovative therapeutic strategies.

Collaborations

Choo has collaborated with notable individuals in his field, including Robert Lindsay Raison and Rosanne Dorothy Dunn, who have contributed to his research endeavors.

Conclusion

Boon Hwa Andre Choo's work in antibody research exemplifies innovation and dedication to improving therapeutic options. His patents and collaborations highlight his impact on the scientific community and the potential for future advancements in medicine.